| 1 | Corneal Opacity in the United States | 4.9 | 1 | Citations (PDF) |
| 2 | Corneal Sensitivity and Neuropathy in Patients With Ocular Graft-Versus-Host Disease | 1.9 | 1 | Citations (PDF) |
| 3 | Antagonizing NK-1R modulates pain perception following corneal injury | 2.5 | 0 | Citations (PDF) |
| 4 | The Neuropeptide α-Melanocyte–Stimulating Hormone Prevents Persistent Corneal Edema following Injury | 3.6 | 7 | Citations (PDF) |
| 5 | Therapeutic Effects of Stimulating the Melanocortin Pathway in Regulating Ocular Inflammation and Cell Death | 4.4 | 7 | Citations (PDF) |
| 6 | Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation | 4.7 | 2 | Citations (PDF) |
| 7 | Effects of Diabetes Mellitus on Corneal Immune Cell Activation and the Development of Keratopathy | 4.8 | 3 | Citations (PDF) |
| 8 | Myeloid-derived suppressor cells promote allograft survival by suppressing regulatory T cell dysfunction in high-risk corneal transplantation | 5.3 | 2 | Citations (PDF) |
| 9 | Local administration of myeloid-derived suppressor cells prevents progression of immune-mediated dry eye disease | 2.5 | 2 | Citations (PDF) |
| 10 | Immunopathological mechanisms and clinical manifestations of ocular graft-versus-host disease following hematopoietic stem cell transplantation | 2.6 | 8 | Citations (PDF) |
| 11 | IL-6 induces Treg dysfunction in desiccating stress-induced dry eye disease | 2.5 | 0 | Citations (PDF) |
| 12 | Assessment of Corneal Graft Outcomes in a Murine Model of Endothelial Keratoplasty | 2.6 | 0 | Citations (PDF) |
| 13 | Acquired immunostimulatory phenotype of migratory CD103+ DCs promotes alloimmunity following corneal transplantation | 5.5 | 0 | Citations (PDF) |
| 14 | Concurrent Limbal Stem Cell Deficiency and Mild Neurotrophic Keratopathy in Graft-Vs-Host Disease | 1.9 | 0 | Citations (PDF) |
| 15 | A Novel Murine Model of Endothelial Keratoplasty | 1.9 | 2 | Citations (PDF) |
| 16 | Autologous serum tears improve corneal nerve density and sensitivity in patients with ocular graft-versus-host disease-associated dry eye disease | 4.2 | 3 | Citations (PDF) |
| 17 | Symptom-based stratification algorithm for heterogeneous symptoms of dry eye disease: a feasibility study | 2.3 | 3 | Citations (PDF) |
| 18 | The impact of donor diabetes on corneal transplant immunity | 5.3 | 3 | Citations (PDF) |
| 19 | Cultivated autologous limbal epithelial cell (CALEC) transplantation: Development of manufacturing process and clinical evaluation of feasibility and safety | 11.3 | 13 | Citations (PDF) |
| 20 | Opposing Roles of Blood-Borne Monocytes and Tissue-Resident Macrophages in Limbal Stem Cell Damage after Ocular Injury | 4.8 | 1 | Citations (PDF) |
| 21 | Development and characterization of a hydrogel-based adhesive patch for sealing open-globe injuries | 9.3 | 34 | Citations (PDF) |
| 22 | The Neuropeptide Alpha-Melanocyte–Stimulating Hormone Is Critical for Corneal Endothelial Cell Protection and Graft Survival after Transplantation | 3.6 | 12 | Citations (PDF) |
| 23 | Bevacizumab in High-Risk Corneal Transplantation | 4.9 | 19 | Citations (PDF) |
| 24 | Autoreactive memory Th17 cells are principally derived from T-bet+RORγt+ Th17/1 effectors | 6.8 | 8 | Citations (PDF) |
| 25 | Immune regulation of the ocular surface | 2.5 | 29 | Citations (PDF) |
| 26 | DryEyeRhythm: A reliable and valid smartphone application for the diagnosis assistance of dry eye | 4.2 | 24 | Citations (PDF) |
| 27 | Impact of aging on the pathophysiology of dry eye disease: A systematic review and meta-analysis | 4.2 | 43 | Citations (PDF) |
| 28 | Neurotrophic Keratopathy in the United States | 4.9 | 16 | Citations (PDF) |
| 29 | Prevalence of neurotrophic keratopathy in patients with chronic ocular graft-versus-host disease | 4.2 | 11 | Citations (PDF) |
| 30 | Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders | 4.2 | 26 | Citations (PDF) |
| 31 | Therapeutic efficacy of topical blockade of substance P in experimental allergic red eye | 4.2 | 6 | Citations (PDF) |
| 32 | The role of Th17 immunity in chronic ocular surface disorders | 4.2 | 31 | Citations (PDF) |
| 33 | Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study | 13.9 | 698 | Citations (PDF) |
| 34 | Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study | 13.9 | 1,590 | Citations (PDF) |
| 35 | Growth factor-eluting hydrogels for management of corneal defects | 5.8 | 9 | Citations (PDF) |
| 36 | Heterogeneity of eye drop use among symptomatic dry eye individuals in Japan: large-scale crowdsourced research using DryEyeRhythm application | 1.6 | 22 | Citations (PDF) |
| 37 | Dry Eye Diagnosis and Management 2021, , 1-28 | | 0 | Citations (PDF) |
| 38 | Advances in the Medical Management of Neurotrophic Keratitis | 2.5 | 14 | Citations (PDF) |
| 39 | Corneal angiogenic privilege and its failure | 2.5 | 40 | Citations (PDF) |
| 40 | Patient-reported burden of dry eye disease in the UK: a cross-sectional web-based survey | 2.0 | 24 | Citations (PDF) |
| 41 | Pigment Epithelium–Derived Factor Enhances the Suppressive Phenotype of Regulatory T Cells in a Murine Model of Dry Eye Disease | 3.6 | 13 | Citations (PDF) |
| 42 | Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM) | 5.9 | 47 | Citations (PDF) |
| 43 | Advanced nanodelivery platforms for topical ophthalmic drug delivery | 7.2 | 46 | Citations (PDF) |
| 44 | Chemical and thermal ocular burns in the United States: An IRIS registry analysis | 4.2 | 9 | Citations (PDF) |
| 45 | Ocular redness – II: Progress in development of therapeutics for the management of conjunctival hyperemia | 4.2 | 10 | Citations (PDF) |
| 46 | A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management | 1.6 | 36 | Citations (PDF) |
| 47 | Ocular redness – I: Etiology, pathogenesis, and assessment of conjunctival hyperemia | 4.2 | 36 | Citations (PDF) |
| 48 | Preclinical Evaluation of the Safety and Efficacy of Cryopreserved Bone Marrow Mesenchymal Stromal Cells for Corneal Repair | 2.3 | 14 | Citations (PDF) |
| 49 | Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy | 1.6 | 19 | Citations (PDF) |
| 50 | Autoimmunity in dry eye disease – An updated review of evidence on effector and memory Th17 cells in disease pathogenicity | 7.1 | 38 | Citations (PDF) |
| 51 | Dry eye disease flares: A rapid evidence assessment | 4.2 | 8 | Citations (PDF) |
| 52 | Corneal lymphangiogenesis in dry eye disease is regulated by substance P/neurokinin-1 receptor system through controlling expression of vascular endothelial growth factor receptor 3 | 4.2 | 20 | Citations (PDF) |
| 53 | Long-term Outcomes of Punctal Cauterization in the Management of Ocular Surface Diseases | 1.9 | 12 | Citations (PDF) |
| 54 | Prevalence and Risk Factors Associated With Corneal Perforation in Chronic Ocular Graft-Versus-Host-Disease | 1.9 | 16 | Citations (PDF) |
| 55 | Smartphone-based digital phenotyping for dry eye toward P4 medicine: a crowdsourced cross-sectional study | 13.3 | 29 | Citations (PDF) |
| 56 | Novel adaptation of a running suture technique in a mouse model of corneal transplantation | 1.2 | 2 | Citations (PDF) |
| 57 | Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy | 4.9 | 173 | Citations (PDF) |
| 58 | Management of meibomian gland dysfunction: a review | 5.4 | 126 | Citations (PDF) |
| 59 | Neurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell Activation | 3.6 | 44 | Citations (PDF) |
| 60 | Regulatory T cells promote corneal endothelial cell survival following transplantation via interleukin-10 | 5.3 | 13 | Citations (PDF) |
| 61 | Letter From the New Editor-in-Chief | 1.9 | 1 | Citations (PDF) |
| 62 | Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application | 4.2 | 72 | Citations (PDF) |
| 63 | Efficacy of cyanoacrylate tissue adhesive in the management of corneal thinning and perforation due to microbial keratitis | 4.2 | 18 | Citations (PDF) |
| 64 | Global Consensus on the Management of Limbal Stem Cell Deficiency | 1.9 | 104 | Citations (PDF) |
| 65 | Association of α-Melanocyte–Stimulating Hormone With Corneal Endothelial Cell Survival During Oxidative Stress and Inflammation-Induced Cell Loss in Donor Tissue | 4.2 | 13 | Citations (PDF) |
| 66 | Regulatory T Cells in Angiogenesis | 0.6 | 47 | Citations (PDF) |
| 67 | Prevalence of Persistent Corneal Epithelial Defects in Chronic Ocular Graft-Versus-Host Disease | 3.8 | 22 | Citations (PDF) |
| 68 | Ciprofloxacin-loaded bioadhesive hydrogels for ocular applications | 5.8 | 54 | Citations (PDF) |
| 69 | Advances and limitations of drug delivery systems formulated as eye drops | 11.3 | 242 | Citations (PDF) |
| 70 | Animal models of high-risk corneal transplantation: A comprehensive review | 2.5 | 11 | Citations (PDF) |
| 71 | Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease | 4.2 | 13 | Citations (PDF) |
| 72 | Clinical and Prodromal Ocular Symptoms in Coronavirus Disease: A Systematic Review and Meta-Analysis 2020, 61, 29 | | 54 | Citations (PDF) |
| 73 | Defining Dry Eye from a Clinical Perspective | 4.5 | 152 | Citations (PDF) |
| 74 | Pigment Epithelium-derived Factor secreted by corneal epithelial cells regulates dendritic cell maturation in dry eye disease | 4.2 | 23 | Citations (PDF) |
| 75 | Restoration of Regulatory T-Cell Function in Dry Eye Disease by Antagonizing Substance P/Neurokinin-1 Receptor | 3.6 | 37 | Citations (PDF) |
| 76 | Sensory neurons directly promote angiogenesis in response to inflammation via substance P signaling | 0.7 | 44 | Citations (PDF) |
| 77 | Association between dry eye and depressive symptoms: Large-scale crowdsourced research using the DryEyeRhythm iPhone application | 4.2 | 42 | Citations (PDF) |
| 78 | Patient-Reported Burden of Dry Eye Disease in the United States: Results of an Online Cross-Sectional Survey | 3.8 | 46 | Citations (PDF) |
| 79 | Aged Mice Exhibit Severe Exacerbations of Dry Eye Disease with an Amplified Memory Th17 Cell Response | 3.6 | 22 | Citations (PDF) |
| 80 | The functions of IL-23 and IL-2 on driving autoimmune effector T-helper 17 cells into the memory pool in dry eye disease | 7.0 | 16 | Citations (PDF) |
| 81 | Pathophysiology of Corneal Graft Rejection 2020, , 87-96 | | 1 | Citations (PDF) |
| 82 | Recovery of Ocular Events with Longer-Term Follow-up in the DREAMMM-2 Study of Single-Agent Belantamab Mafodotin (Belamaf) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) | 1.0 | 6 | Citations (PDF) |
| 83 | Stratification of Individual Symptoms of Contact Lens–Associated Dry Eye Using the iPhone App DryEyeRhythm: Crowdsourced Cross-Sectional Study | 5.3 | 25 | Citations (PDF) |
| 84 | Immune Checkpoint Inhibitors and Corneal Transplant Rejection: A Call for Awareness | 2.1 | 7 | Citations (PDF) |
| 85 | Future Directions in the Field of Cornea 2020, , 381-388 | | 0 | Citations (PDF) |
| 86 | Keratoconus progression associated with hormone replacement therapy | 0.9 | 21 | Citations (PDF) |
| 87 | The purinergic receptor antagonist oxidized adenosine triphosphate suppresses immune-mediated corneal allograft rejection | 3.7 | 5 | Citations (PDF) |
| 88 | Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study | 2.3 | 7 | Citations (PDF) |
| 89 | Thrombospondin-1 in ocular surface health and disease | 4.2 | 34 | Citations (PDF) |
| 90 | Methods for Assessing Corneal Opacity | 2.5 | 19 | Citations (PDF) |
| 91 | Medical and surgical management of conjunctivochalasis | 4.2 | 19 | Citations (PDF) |
| 92 | Retinal microglia initiate neuroinflammation in ocular autoimmunity | 7.7 | 129 | Citations (PDF) |
| 93 | Sutureless repair of corneal injuries using naturally derived bioadhesive hydrogels | 11.3 | 254 | Citations (PDF) |
| 94 | Oral guaifenesin for treatment of filamentary keratitis: A pilot study | 4.2 | 3 | Citations (PDF) |
| 95 | In Vivo Confocal Microscopy Demonstrates Increased Immune Cell Densities in Corneal Graft Rejection Correlating With Signs and Symptoms | 3.8 | 16 | Citations (PDF) |
| 96 | Estimated Prevalence and Incidence of Dry Eye Disease Based on Coding Analysis of a Large, All-age United States Health Care System | 3.8 | 147 | Citations (PDF) |
| 97 | Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency | 1.9 | 236 | Citations (PDF) |
| 98 | <p>Dry eye disease ranking among common reasons for seeking eye care in a large US claims database</p> | 2.1 | 45 | Citations (PDF) |
| 99 | Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases | 0.6 | 76 | Citations (PDF) |
| 100 | Outcomes of Cyanoacrylate Tissue Adhesive Application in Corneal Thinning and Perforation | 1.9 | 49 | Citations (PDF) |
| 101 | Reply | 1.9 | 0 | Citations (PDF) |
| 102 | Local Delivery of Regulatory T Cells Promotes Corneal Allograft Survival | 1.0 | 30 | Citations (PDF) |
| 103 | Impact of Dry Eye on Visual Acuity and Contrast Sensitivity: Dry Eye Assessment and Management Study | 1.6 | 45 | Citations (PDF) |
| 104 | Limbal and Conjunctival Epithelial Thickness in Ocular Graft-Versus-Host Disease | 1.9 | 3 | Citations (PDF) |
| 105 | Ocular adhesives: Design, chemistry, crosslinking mechanisms, and applications | 12.3 | 98 | Citations (PDF) |
| 106 | Microglia Regulate Neuroglia Remodeling in Various Ocular and Retinal Injuries | 0.6 | 32 | Citations (PDF) |
| 107 | Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study | 3.8 | 17 | Citations (PDF) |
| 108 | A standardized methodology for longitudinal assessment of corneal endothelial morphometry in eye banked corneas | 1.2 | 4 | Citations (PDF) |
| 109 | The Role of Microglia and Peripheral Monocytes in Retinal Damage after Corneal Chemical Injury | 3.6 | 44 | Citations (PDF) |
| 110 | Web-based longitudinal remote assessment of dry eye symptoms | 4.2 | 16 | Citations (PDF) |
| 111 | Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function | 3.3 | 56 | Citations (PDF) |
| 112 | Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation | 5.6 | 15 | Citations (PDF) |
| 113 | Factors Influencing the Diagnostic Accuracy of Laser-Scanning In Vivo Confocal Microscopy for Acanthamoeba Keratitis | 1.9 | 24 | Citations (PDF) |
| 114 | A New Frontier in Curing Corneal Blindness | 25.5 | 12 | Citations (PDF) |
| 115 | Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease | 3.8 | 20 | Citations (PDF) |
| 116 | Subtarsal Fibrosis Is Associated With Ocular Surface Epitheliopathy in Graft-Versus-Host Disease | 3.8 | 33 | Citations (PDF) |
| 117 | Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection | 1.9 | 23 | Citations (PDF) |
| 118 | When Clarity Is Crucial: Regulating Ocular Surface Immunity | 15.9 | 64 | Citations (PDF) |
| 119 | Conjunctivochalasis: a systematic review | 5.4 | 38 | Citations (PDF) |
| 120 | Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities | 1.9 | 30 | Citations (PDF) |
| 121 | Permanent neuroglial remodeling of the retina following infiltration of CSF1R inhibition-resistant peripheral monocytes | 7.7 | 49 | Citations (PDF) |
| 122 | Regulatory T Cell Modulation of Cytokine and Cellular Networks in Corneal Graft Rejection | 0.8 | 17 | Citations (PDF) |
| 123 | Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD | 4.2 | 17 | Citations (PDF) |
| 124 | The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease | 4.2 | 29 | Citations (PDF) |
| 125 | Pathological conversion of regulatory T cells is associated with loss of allotolerance | 3.7 | 78 | Citations (PDF) |
| 126 | Vasoactive Intestinal Peptide Promotes Corneal Allograft Survival | 3.6 | 28 | Citations (PDF) |
| 127 | Exophiala phaeomuriformis Fungal Keratitis: Case Report and In Vivo Confocal Microscopy Findings | 1.6 | 15 | Citations (PDF) |
| 128 | Elevated Neutrophil Elastase in Tears of Ocular Graft-Versus-Host Disease Patients | 3.8 | 37 | Citations (PDF) |
| 129 | Ageing and ocular surface immunity | 3.9 | 29 | Citations (PDF) |
| 130 | Optimising keratoplasty for Peters' anomaly in infants using spectral-domain optical coherence tomography | 3.9 | 13 | Citations (PDF) |
| 131 | Mechanisms of Retinal Damage after Ocular Alkali Burns | 3.6 | 59 | Citations (PDF) |
| 132 | Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation | 3.7 | 27 | Citations (PDF) |
| 133 | Kinetics of Angiogenic Responses in Corneal Transplantation | 1.9 | 40 | Citations (PDF) |
| 134 | A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease | 1.9 | 27 | Citations (PDF) |
| 135 | Sensitivity and Specificity of Laser-Scanning In Vivo Confocal Microscopy for Filamentous Fungal Keratitis: Role of Observer Experience | 3.8 | 43 | Citations (PDF) |
| 136 | Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity | 6.8 | 46 | Citations (PDF) |
| 137 | Determinants of Ocular Pain Severity in Patients With Dry Eye Disease | 3.8 | 29 | Citations (PDF) |
| 138 | Proangiogenic Function of T Cells in Corneal Transplantation | 1.0 | 25 | Citations (PDF) |
| 139 | IFN-γ–Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity | 0.6 | 74 | Citations (PDF) |
| 140 | Patients' Perceived Treatment Effectiveness in Dry Eye Disease | 1.9 | 8 | Citations (PDF) |
| 141 | Review: The function of regulatory T cells at the ocular surface | 4.2 | 29 | Citations (PDF) |
| 142 | Management of high-risk corneal transplantation | 5.4 | 115 | Citations (PDF) |
| 143 | Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis | 13.9 | 2,274 | Citations (PDF) |
| 144 | TFOS DEWS II Management and Therapy Report | 4.2 | 960 | Citations (PDF) |
| 145 | Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis | 13.9 | 1,516 | Citations (PDF) |
| 146 | Patients With Dry Eye Disease and Low Subbasal Nerve Density Are at High Risk for Accelerated Corneal Endothelial Cell Loss | 1.9 | 37 | Citations (PDF) |
| 147 | Infliximab after Boston Keratoprosthesis in Stevens–Johnson Syndrome: An Update | 1.6 | 21 | Citations (PDF) |
| 148 | Kinetics of Corneal Antigen Presenting Cells in Experimental Dry Eye Disease | 1.8 | 29 | Citations (PDF) |
| 149 | Evaluating Corneal Fluorescein Staining Using a Novel Automated Method 2017, 58, BIO168 | | 46 | Citations (PDF) |
| 150 | Systemic immunomodulatory strategies in high-risk corneal transplantation | 0.9 | 51 | Citations (PDF) |
| 151 | T Cell–Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration 2017, 58, 1330 | | 31 | Citations (PDF) |
| 152 | Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1 2017, 58, 5507 | | 56 | Citations (PDF) |
| 153 | Evaluating Changes in Ocular Redness Using a Novel Automated Method | 2.3 | 9 | Citations (PDF) |
| 154 | Scaling and maintenance of corneal thickness during aging | 2.5 | 15 | Citations (PDF) |
| 155 | Effect of Penetrating Keratoplasty and Keratoprosthesis Implantation on the Posterior Segment of the Eye 2016, 57, 1643 | | 17 | Citations (PDF) |
| 156 | Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis 2016, 57, 1457 | | 25 | Citations (PDF) |
| 157 | In Vivo Confocal Microscopy in Dry Eye Disease Associated With Chronic Graft-Versus-Host Disease 2016, 57, 4686 | | 43 | Citations (PDF) |
| 158 | E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation | 1.0 | 25 | Citations (PDF) |
| 159 | Overestimation of Corneal Endothelial Cell Density in Smaller Frame Sizes in In Vivo Confocal Microscopy | 1.9 | 8 | Citations (PDF) |
| 160 | Impaired Function of Peripherally Induced Regulatory T Cells in Hosts at High Risk of Graft Rejection | 3.7 | 40 | Citations (PDF) |
| 161 | Corrigendum to “Corneal innervation as a window to peripheral neuropathies” [Exp. Eye Res. 113 (2013) 148–150] | 2.5 | 0 | Citations (PDF) |
| 162 | Validity and Reliability of a Novel Ocular Pain Assessment Survey (OPAS) in Quantifying and Monitoring Corneal and Ocular Surface Pain | 4.9 | 79 | Citations (PDF) |
| 163 | A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease | 4.9 | 59 | Citations (PDF) |
| 164 | Alloimmunity and Tolerance in Corneal Transplantation | 0.6 | 96 | Citations (PDF) |
| 165 | IL-17 Augments B Cell Activation in Ocular Surface Autoimmunity | 0.6 | 56 | Citations (PDF) |
| 166 | In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation | 1.0 | 65 | Citations (PDF) |
| 167 | Patients' Perspectives on Their Dry Eye Disease | 4.2 | 12 | Citations (PDF) |
| 168 | Ocular Manifestations of Inherited Phospholipase-Cγ2–Associated Antibody Deficiency and Immune Dysregulation | 1.9 | 8 | Citations (PDF) |
| 169 | Novel Insights Into the Immunoregulatory Function and Localization of Dendritic Cells | 1.9 | 30 | Citations (PDF) |
| 170 | Neuropeptide substance P and the immune response | 5.6 | 337 | Citations (PDF) |
| 171 | Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease | 1.9 | 15 | Citations (PDF) |
| 172 | PTK7
<sup>+</sup>
Mononuclear Cells Express VEGFR2 and Contribute to Vascular Stabilization by Upregulating Angiopoietin-1 | 6.2 | 9 | Citations (PDF) |
| 173 | Sufficient Evidence for Lymphatics in the Developing and Adult Human Choroid? 2015, 56, 6709 | | 17 | Citations (PDF) |
| 174 | Contralateral Clinically Unaffected Eyes of Patients With Unilateral Infectious Keratitis Demonstrate a Sympathetic Immune Response 2015, 56, 6612 | | 56 | Citations (PDF) |
| 175 | Involvement of Corneal Lymphangiogenesis in a Mouse Model of Allergic Eye Disease 2015, 56, 3140 | | 47 | Citations (PDF) |
| 176 | Corneal Epithelial Immune Dendritic Cell Alterations in Subtypes of Dry Eye Disease: A Pilot In Vivo Confocal Microscopic Study 2015, 56, 7179 | | 125 | Citations (PDF) |
| 177 | Effects of Corneal Nerve Density on the Response to Treatment in Dry Eye Disease | 4.9 | 89 | Citations (PDF) |
| 178 | Outcomes of phacoemulsification in patients with chronic ocular graft-versus-host disease | 1.9 | 18 | Citations (PDF) |
| 179 | Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease | 4.9 | 70 | Citations (PDF) |
| 180 | In Vivo Confocal Microscopic Changes of the Corneal Epithelium and Stroma in Patients With Herpes Zoster Ophthalmicus | 3.8 | 14 | Citations (PDF) |
| 181 | Alteration of Galectin-3 in Tears of Patients With Dry Eye Disease | 3.8 | 44 | Citations (PDF) |
| 182 | Reduced Corneal Endothelial Cell Density in Patients With Dry Eye Disease | 3.8 | 54 | Citations (PDF) |
| 183 | Comparison of Two Questionnaires for Dry Eye Symptom Assessment | 4.9 | 125 | Citations (PDF) |
| 184 | Onset of Ocular Graft-Versus-Host Disease Symptoms After Allogeneic Hematopoietic Stem Cell Transplantation | 1.9 | 57 | Citations (PDF) |
| 185 | VEGF-trap Aflibercept Significantly Improves Long-term Graft Survival in High-risk Corneal Transplantation | 1.0 | 67 | Citations (PDF) |
| 186 | Degeneration and Regeneration of Subbasal Corneal Nerves after Infectious Keratitis | 4.9 | 54 | Citations (PDF) |
| 187 | Ocular surgical models for immune and angiogenic responses | 1.2 | 31 | Citations (PDF) |
| 188 | Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity | 0.3 | 53 | Citations (PDF) |
| 189 | A Novel Murine Model for Keratoprosthesis 2014, 55, 3681 | | 7 | Citations (PDF) |
| 190 | Consensus Statement on the Immunohistochemical Detection of Ocular Lymphatic Vessels 2014, 55, 6440 | | 71 | Citations (PDF) |
| 191 | CCR7 Is Critical for the Induction and Maintenance of Th17 Immunity in Dry Eye Disease 2014, 55, 5871 | | 46 | Citations (PDF) |
| 192 | Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival | 1.9 | 28 | Citations (PDF) |
| 193 | Alkali Burn to the Eye | 1.9 | 61 | Citations (PDF) |
| 194 | Extraorbital Lacrimal Gland Excision | 1.9 | 58 | Citations (PDF) |
| 195 | Effects of Topical Janus Kinase Inhibition on Ocular Surface Inflammation and Immunity | 1.9 | 29 | Citations (PDF) |
| 196 | CCL-21 Conditioned Regulatory T Cells Induce Allotolerance through Enhanced Homing to Lymphoid Tissue | 0.6 | 39 | Citations (PDF) |
| 197 | What is the Value of Incorporating Tear Osmolarity Measurement in Assessing Patient Response to Therapy in Dry Eye Disease? | 3.8 | 62 | Citations (PDF) |
| 198 | Differentiation Potential of Limbal Fibroblasts and Bone Marrow Mesenchymal Stem Cells to Corneal Epithelial Cells | 3.3 | 73 | Citations (PDF) |
| 199 | The Resolvin D1 Analogue Controls Maturation of Dendritic Cells and Suppresses Alloimmunity in Corneal Transplantation 2014, 55, 5944 | | 52 | Citations (PDF) |
| 200 | The Value of Tear Osmolarity as a Metric in Evaluating the Response to Dry Eye Therapy in the Clinic and in Clinical Trials | 3.8 | 4 | Citations (PDF) |
| 201 | Ocular Graft-versus-Host Disease: A Review | 5.4 | 183 | Citations (PDF) |
| 202 | Corneal innervation as a window to peripheral neuropathies | 2.5 | 38 | Citations (PDF) |
| 203 | Effect of Desiccating Environmental Stress Versus Systemic Muscarinic AChR Blockade on Dry Eye Immunopathogenesis 2013, 54, 2457 | | 48 | Citations (PDF) |
| 204 | The CCR6/CCL20 Axis Mediates Th17 Cell Migration to the Ocular Surface in Dry Eye Disease 2013, 54, 4081 | | 64 | Citations (PDF) |
| 205 | On the Edge | 4.2 | 12 | Citations (PDF) |
| 206 | Topical Interleukin 1 Receptor Antagonist for Treatment of Dry Eye Disease | 4.2 | 96 | Citations (PDF) |
| 207 | Nerves and Neovessels Inhibit Each Other in the Cornea 2013, 54, 813 | | 64 | Citations (PDF) |
| 208 | IL-1 receptor antagonist in the treatment of dry eye disease | 0.9 | 0 | Citations (PDF) |
| 209 | International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I) | 3.7 | 190 | Citations (PDF) |
| 210 | Topical Ranibizumab as a Treatment of Corneal Neovascularization | 1.9 | 75 | Citations (PDF) |
| 211 | Bilateral corneal ulceration in ocular graft-versus-host disease | 2.1 | 33 | Citations (PDF) |
| 212 | The Ocular Redness Index: A Novel Automated Method for Measuring Ocular Injection 2013, 54, 4821 | | 44 | Citations (PDF) |
| 213 | Blockade of Prolymphangiogenic Vascular Endothelial Growth Factor C in Dry Eye Disease | 2.4 | 64 | Citations (PDF) |
| 214 | Gamma-Irradiation Reduces the Allogenicity of Donor Corneas 2012, 53, 7151 | | 37 | Citations (PDF) |
| 215 | Dry Eye Disease | 2.4 | 466 | Citations (PDF) |
| 216 | Expression of Toll-Like Receptor 4 Contributes to Corneal Inflammation in Experimental Dry Eye Disease 2012, 53, 5632 | | 68 | Citations (PDF) |
| 217 | PDE4 Inhibition Suppresses IL-17–Associated Immunity in Dry Eye Disease 2012, 53, 3584 | | 29 | Citations (PDF) |
| 218 | Vascular Endothelial Growth Factor-C Promotes Alloimmunity by Amplifying Antigen-Presenting Cell Maturation and Lymphangiogenesis 2012, 53, 1244 | | 55 | Citations (PDF) |
| 219 | Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable | 3.9 | 70 | Citations (PDF) |
| 220 | b-FGF Induces Corneal Blood and Lymphatic Vessel Growth in a Spatially Distinct Pattern | 1.9 | 18 | Citations (PDF) |
| 221 | Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) Vs Bevacizumab (Avastin) | 4.2 | 137 | Citations (PDF) |
| 222 | Efficacy of Topical Blockade of Interleukin-1 in Experimental Dry Eye Disease | 3.8 | 75 | Citations (PDF) |
| 223 | Short-Term Topical Bevacizumab in the Treatment of Stable Corneal Neovascularization | 3.8 | 43 | Citations (PDF) |
| 224 | Dependence of Corneal Stem/Progenitor Cells on Ocular Surface Innervation 2012, 53, 867 | | 116 | Citations (PDF) |
| 225 | Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation | 3.0 | 47 | Citations (PDF) |
| 226 | Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease | 13.3 | 252 | Citations (PDF) |
| 227 | Inflammatory Corneal Neovascularization: Etiopathogenesis | 2.5 | 62 | Citations (PDF) |
| 228 | A Novel Function for Programmed Death Ligand-1 | 3.6 | 53 | Citations (PDF) |
| 229 | Characterization of Langerin-Expressing Dendritic Cell Subsets in the Normal Cornea 2011, 52, 4598 | | 72 | Citations (PDF) |
| 230 | Inflammation and the Nervous System: The Connection in the Cornea in Patients with Infectious Keratitis 2011, 52, 5136 | | 200 | Citations (PDF) |
| 231 | Therapeutic Efficacy of Topical Epigallocatechin Gallate in Murine Dry Eye | 1.9 | 57 | Citations (PDF) |
| 232 | A novel pro-lymphangiogenic function for Th17/IL-17Blood, 2011, 118, 4630-4634 | 1.0 | 100 | Citations (PDF) |
| 233 | Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7–dependent pathwayBlood, 2011, 117, 5762-5771 | 1.0 | 72 | Citations (PDF) |
| 234 | Corneal Endothelial Cells Are Protected from Apoptosis by Gene Therapy | 3.4 | 32 | Citations (PDF) |
| 235 | Delayed Type Hypersensitivity in the Pathogenesis of Recurrent Herpes Stromal Keratitis | 2.5 | 8 | Citations (PDF) |
| 236 | Corneal Penetration of Topical and Subconjunctival Bevacizumab 2011, 52, 8718 | | 94 | Citations (PDF) |
| 237 | Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes | 8.1 | 144 | Citations (PDF) |
| 238 | Relapsing Polychondritis: Systemic and Ocular Manifestations, Differential Diagnosis, Management, and Prognosis | 2.5 | 48 | Citations (PDF) |
| 239 | Interferon-γ-secreting NK cells promote induction of dry eye disease | 3.0 | 70 | Citations (PDF) |
| 240 | A Novel Mouse Model for Neurotrophic Keratopathy: Trigeminal Nerve Stereotactic Electrolysis through the Brain 2011, 52, 2532 | | 72 | Citations (PDF) |
| 241 | Keratoconjunctivitis Sicca Manifestations in Ocular Graft Versus Host Disease: Pathogenesis, Presentation, Prevention, and Treatment | 2.5 | 29 | Citations (PDF) |
| 242 | The culture and transplantation of human limbal stem cells | 4.2 | 49 | Citations (PDF) |
| 243 | Regulation of T-Cell Chemotaxis by Programmed Death-Ligand 1 (PD-L1) in Dry Eye–Associated Corneal Inflammation 2010, 51, 3418 | | 57 | Citations (PDF) |
| 244 | Effects of Topical and Subconjunctival Bevacizumab in High-Risk Corneal Transplant Survival 2010, 51, 2411 | | 80 | Citations (PDF) |
| 245 | Role of CCR7 in Facilitating Direct Allosensitization and Regulatory T-Cell Function in High-Risk Corneal Transplantation 2010, 51, 816 | | 24 | Citations (PDF) |
| 246 | Evidence of Corneal Lymphangiogenesis in Dry Eye Disease | 2.4 | 93 | Citations (PDF) |
| 247 | Thrombospondin-1 Derived from APCs Regulates Their Capacity for Allosensitization | 0.6 | 44 | Citations (PDF) |
| 248 | Corneal Sensation and Subbasal Nerve Alterations in Patients with Herpes Simplex Keratitis | 4.9 | 254 | Citations (PDF) |
| 249 | Depletion of Passenger Leukocytes from Corneal Grafts: An Effective Means of Promoting Transplant Survival? 2009, 50, 3137 | | 21 | Citations (PDF) |
| 250 | Characterization of Effector T Cells in Dry Eye Disease 2009, 50, 3802 | | 128 | Citations (PDF) |
| 251 | Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation | 0.6 | 217 | Citations (PDF) |
| 252 | Prevalence of Dry Eye Disease Among US Men | 2.4 | 483 | Citations (PDF) |
| 253 | Autoimmunity in Dry Eye Is Due to Resistance of Th17 to Treg Suppression | 0.6 | 250 | Citations (PDF) |
| 254 | Anti-angiogenesis Effect of the Novel Anti-inflammatory and Pro-resolving Lipid Mediators 2009, 50, 4743 | | 130 | Citations (PDF) |
| 255 | Blocking the path of lymphatic vessels | 25.6 | 33 | Citations (PDF) |
| 256 | Corneal Lymphangiogenesis: Implications in Immunity | 2.5 | 36 | Citations (PDF) |
| 257 | Topical Bevacizumab in the Treatment of Corneal Neovascularization | 2.4 | 166 | Citations (PDF) |
| 258 | Contribution of Macrophages to Angiogenesis Induced by Vascular Endothelial Growth Factor Receptor-3-Specific Ligands | 3.6 | 81 | Citations (PDF) |
| 259 | High-frequency Topical Cyclosporine 0.05% in the Treatment of Severe Dry Eye Refractory to Twice-daily Regimen | 1.9 | 82 | Citations (PDF) |
| 260 | The Structure and Function of the Limbal Stem Cell and the Disease States Associated With Limbal Stem Cell Deficiency | 0.6 | 40 | Citations (PDF) |
| 261 | Corneal Nerve Alterations in Dry Eye-associated Ocular Surface Disease | 0.6 | 50 | Citations (PDF) |
| 262 | Differential Roles of Direct and Indirect Allorecognition Pathways in the Rejection of Skin and Corneal Transplants | 1.0 | 44 | Citations (PDF) |
| 263 | Amelioration of Murine Dry Eye Disease by Topical Antagonist to Chemokine Receptor 2 | 2.4 | 66 | Citations (PDF) |
| 264 | Modulation of Integrin α4β1 (VLA-4) in Dry Eye Disease | 2.4 | 53 | Citations (PDF) |
| 265 | Chimeric Solid Tissue Grafts Diminish Allospecific Immunity | 0.7 | 0 | Citations (PDF) |
| 266 | Impact of Dry Eye Syndrome on Vision-Related Quality of Life | 3.8 | 674 | Citations (PDF) |
| 267 | Mist Delivery of Eye Medication to the Anterior Segment | 3.8 | 7 | Citations (PDF) |
| 268 | Development and Validation of a Short Global Dry Eye Symptom Index | 4.2 | 179 | Citations (PDF) |
| 269 | Validation and Repeatability of a Short Questionnaire for Dry Eye Syndrome | 3.8 | 118 | Citations (PDF) |
| 270 | Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision | 7.7 | 233 | Citations (PDF) |
| 271 | Radiotherapy-Induced Ocular Surface Disease | 1.9 | 43 | Citations (PDF) |
| 272 | Chronic Ocular Surface Disease after Allogeneic Bone Marrow Transplantation | 4.2 | 68 | Citations (PDF) |
| 273 | Corneal Antigen Presentation: Molecular Regulation and Functional Implications | 4.2 | 13 | Citations (PDF) |
